Germline (G)BRCA1/2 Mutations (M) and Hematological Toxicities in Patients (PTS) with Triple Negative Breast Cancer (TNBC) Treated with Neoadjuvant Chemotherapy (NACT)
Furlanetto J, Moebus V, Schneeweiss A, Rhiem K, Tesch H, Blohmer JU, Luebbe K, Untch M, Salat C, Huober J, Klare P, Schmutzler R, Couch FJ, Lederer B, Gerber B, Zahm DM, Bauerfeind I, Nekljudova V, Hanusch C, Jackisch C, Link T, Loibl S, Fasching P (2020)
Publication Type: Conference contribution
Publication year: 2020
Journal
Publisher: KARGER
City/Town: BASEL
Pages Range: 22-22
Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT
DOI: 10.1158/1538-7445.sabcs19-p6-10-03
Authors with CRIS profile
Involved external institutions
GBG Forschungs GmbH (German Breast Group)
Germany (DE)
Universitätsklinikum Carl Gustav Carus Dresden
Germany (DE)
Rotkreuzklinikum München
Germany (DE)
Universitätsklinikum Köln
Germany (DE)
Diakoniekrankenhaus Henriettenstiftung
Germany (DE)
Cardioangiologische Centrum Bethanien
Germany (DE)
Charité - Universitätsmedizin Berlin
Germany (DE)
Klinikum Südstadt Rostock
Germany (DE)
Universitätsklinikum Ulm
Germany (DE)
HELIOS Kliniken
Germany (DE)
Sana Kliniken AG
Germany (DE)
Klinikum Landshut
Germany (DE)
Universitätsklinikum Frankfurt am Main (KGU)
Germany (DE)
SRH Wald-Klinikum Gera
Germany (DE)
Mayo Clinic
United States (USA) (US)
Deutsches Krebsforschungszentrum (DKFZ)
Germany (DE)
Germany (DE)
Universitätsklinikum Carl Gustav Carus Dresden
Germany (DE)
Rotkreuzklinikum München
Germany (DE)
Universitätsklinikum Köln
Germany (DE)
Diakoniekrankenhaus Henriettenstiftung
Germany (DE)
Cardioangiologische Centrum Bethanien
Germany (DE)
Charité - Universitätsmedizin Berlin
Germany (DE)
Klinikum Südstadt Rostock
Germany (DE)
Universitätsklinikum Ulm
Germany (DE)
HELIOS Kliniken
Germany (DE)
Sana Kliniken AG
Germany (DE)
Klinikum Landshut
Germany (DE)
Universitätsklinikum Frankfurt am Main (KGU)
Germany (DE)
SRH Wald-Klinikum Gera
Germany (DE)
Mayo Clinic
United States (USA) (US)
Deutsches Krebsforschungszentrum (DKFZ)
Germany (DE)
How to cite
APA:
Furlanetto, J., Moebus, V., Schneeweiss, A., Rhiem, K., Tesch, H., Blohmer, J.-U.,... Fasching, P. (2020). Germline (G)BRCA1/2 Mutations (M) and Hematological Toxicities in Patients (PTS) with Triple Negative Breast Cancer (TNBC) Treated with Neoadjuvant Chemotherapy (NACT). In ONCOLOGY RESEARCH AND TREATMENT (pp. 22-22). BASEL: KARGER.
MLA:
Furlanetto, Jenny, et al. "Germline (G)BRCA1/2 Mutations (M) and Hematological Toxicities in Patients (PTS) with Triple Negative Breast Cancer (TNBC) Treated with Neoadjuvant Chemotherapy (NACT)." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2020. 22-22.
BibTeX: Download